[go: up one dir, main page]

HK1245071B - 用於回肠-空肠给药的组合物 - Google Patents

用於回肠-空肠给药的组合物 Download PDF

Info

Publication number
HK1245071B
HK1245071B HK18104152.6A HK18104152A HK1245071B HK 1245071 B HK1245071 B HK 1245071B HK 18104152 A HK18104152 A HK 18104152A HK 1245071 B HK1245071 B HK 1245071B
Authority
HK
Hong Kong
Prior art keywords
dosage form
oral dosage
solid oral
pharmaceutically acceptable
compound
Prior art date
Application number
HK18104152.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1245071A1 (zh
Inventor
Philip A. NUNN
Bret Berner
Mohammad Reza MASJEDIZADEH
Original Assignee
Principia Biopharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Principia Biopharma Inc. filed Critical Principia Biopharma Inc.
Priority claimed from PCT/US2015/000515 external-priority patent/WO2016105582A1/en
Publication of HK1245071A1 publication Critical patent/HK1245071A1/zh
Publication of HK1245071B publication Critical patent/HK1245071B/zh

Links

HK18104152.6A 2014-12-24 2015-12-23 用於回肠-空肠给药的组合物 HK1245071B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462096812P 2014-12-24 2014-12-24
US62/096,812 2014-12-24
PCT/US2015/000515 WO2016105582A1 (en) 2014-12-24 2015-12-23 Compositions for ileo-jejunal drug delivery

Publications (2)

Publication Number Publication Date
HK1245071A1 HK1245071A1 (zh) 2018-08-24
HK1245071B true HK1245071B (zh) 2023-05-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP3236943B1 (en) Compositions for ileo-jejunal drug delivery
US6677342B2 (en) Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
JP2022033758A (ja) 生理活性の強い、ｕｒａｔ１のインヒビターを含む医薬組成物
CN109475510B (zh) 普瑞巴林的延长释放剂型
US9642808B2 (en) Extended release compositions comprising mycophenolate sodium and processes thereof
CN101969931A (zh) 包含霉酚酸的调节释放药物组合物及其方法
CN102917697A (zh) 用于高剂量的水溶性和吸湿性药物的控释剂型
EP2200591A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
CN101636152A (zh) 含有西洛他唑的控释制剂及其制备方法
US20210154180A1 (en) Formulation having improved ph-dependent drug-release characteristics containing esomeprazole or pharmaceutically acceptable salt thereof
US20140050784A1 (en) Pharmaceutical compositions of memantine
WO2009047799A1 (en) High dose solid unit oral pharmaceutical dosage form of mycophenolate sodium and process for making same
CA3245018A1 (en) THERAPEUTIC COMPOUNDS, FORMULATIONS AND THEIR USE
RU2651460C2 (ru) Комбинированная композиция, содержащая метформин замедленного высвобождения и ингибитор HMG-CoA-редуктазы немедленного высвобождения
KR101925590B1 (ko) 개선된 생체이용률을 갖는 페노피브릭산 제제
KR20210096162A (ko) 의약 조성물
HK1245071B (zh) 用於回肠-空肠给药的组合物
KR20090107959A (ko) 약제학적 제제
US20050171119A1 (en) Pharmaceutical formulations with modified release
WO2017029226A1 (en) Solid pharmaceutical composition of abacavir, lamivudine, and efavirenz
US20250170065A1 (en) Therapeutic compounds, formulations, and use thereof
WO2020097328A1 (en) Fixed dose pharmaceutical compositions for treating overactive bladder and related conditions
KR102330953B1 (ko) 소듐-1-[6-(모르폴린-4-일)피리미딘-4-일]-4-(1h-1,2,3-트리아졸-1-일)-1h-피라졸-5-올레이트를 함유하는 제약 투여 형태
US20080206338A1 (en) Controlled release formulations of an alpha-adrenergic receptor antagonist
EP4401707A1 (en) Multiparticulate dosage forms comprising deutetrabenazine